Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Timothy Hill is active.

Publication


Featured researches published by Timothy Hill.


Journal of Clinical Investigation | 2013

Discovering naturally processed antigenic determinants that confer protective T cell immunity

Pavlo Gilchuk; Charles T. Spencer; Stephanie B. Conant; Timothy Hill; Jennifer J. Gray; Xinnan Niu; Mu Zheng; John J. Erickson; Kelli L. Boyd; K. Jill McAfee; Carla Oseroff; Sine Reker Hadrup; Jack R. Bennink; William H. Hildebrand; Kathryn M. Edwards; James E. Crowe; John V. Williams; Søren Buus; Alessandro Sette; Ton N. M. Schumacher; Andrew J. Link; Sebastian Joyce

CD8+ T cells (TCD8) confer protective immunity against many infectious diseases, suggesting that microbial TCD8 determinants are promising vaccine targets. Nevertheless, current T cell antigen identification approaches do not discern which epitopes drive protective immunity during active infection - information that is critical for the rational design of TCD8-targeted vaccines. We employed a proteomics-based approach for large-scale discovery of naturally processed determinants derived from a complex pathogen, vaccinia virus (VACV), that are presented by the most frequent representatives of four major HLA class I supertypes. Immunologic characterization revealed that many previously unidentified VACV determinants were recognized by smallpox-vaccinated human peripheral blood cells in a variegated manner. Many such determinants were recognized by HLA class I-transgenic mouse immune TCD8 too and elicited protective TCD8 immunity against lethal intranasal VACV infection. Notably, efficient processing and stable presentation of immune determinants as well as the availability of naive TCD8 precursors were sufficient to drive a multifunctional, protective TCD8 response. Our approach uses fundamental insights into T cell epitope processing and presentation to define targets of protective TCD8 immunity within human pathogens that have complex proteomes, suggesting that this approach has general applicability in vaccine sciences.


PLOS Pathogens | 2015

Border Patrol Gone Awry: Lung NKT Cell Activation by Francisella tularensis Exacerbates Tularemia-Like Disease

Timothy Hill; Pavlo Gilchuk; Basak B. Cicek; Maria A. Osina; Kelli L. Boyd; Douglas M. Durrant; Dennis W. Metzger; Kamal M. Khanna; Sebastian Joyce

The respiratory mucosa is a major site for pathogen invasion and, hence, a site requiring constant immune surveillance. The type I, semi-invariant natural killer T (NKT) cells are enriched within the lung vasculature. Despite optimal positioning, the role of NKT cells in respiratory infectious diseases remains poorly understood. Hence, we assessed their function in a murine model of pulmonary tularemia—because tularemia is a sepsis-like proinflammatory disease and NKT cells are known to control the cellular and humoral responses underlying sepsis. Here we show for the first time that respiratory infection with Francisella tularensis live vaccine strain resulted in rapid accumulation of NKT cells within the lung interstitium. Activated NKT cells produced interferon-γ and promoted both local and systemic proinflammatory responses. Consistent with these results, NKT cell-deficient mice showed reduced inflammatory cytokine and chemokine response yet they survived the infection better than their wild type counterparts. Strikingly, NKT cell-deficient mice had increased lymphocytic infiltration in the lungs that organized into tertiary lymphoid structures resembling induced bronchus-associated lymphoid tissue (iBALT) at the peak of infection. Thus, NKT cell activation by F. tularensis infection hampers iBALT formation and promotes a systemic proinflammatory response, which exacerbates severe pulmonary tularemia-like disease in mice.


Current Opinion in Immunology | 2015

Discovering protective CD8 T cell epitopes—no single immunologic property predicts it!

Pavlo Gilchuk; Timothy Hill; John T. Wilson; Sebastian Joyce

Once a burgeoning field of study, over the past decade or so, T cell epitope discovery has lost some luster. The contributory factors perchance are the general notion that any newly discovered epitope will reveal very little about an immune response and that knowledge of epitopes are less critical for vaccine design. Despite these notions, the breadth and depth of T cell epitopes derived from clinically important microbial agents of human diseases largely remain ill defined. We review here a flurry of recent reports that have rebirthed the field. These reports reveal that epitope discovery is an essential step toward rational vaccine design and critical for monitoring vaccination efficacy. The new findings also indicate that neither immunogenicity nor immunodominance predict protective immunity. Hence, an immunogenic epitope is but a peptide unless proven protective against disease.


Frontiers in Immunology | 2017

Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective.

Amrendra Kumar; Naveenchandra Suryadevara; Timothy Hill; Jelena S. Bezbradica; Luc Van Kaer; Sebastian Joyce

Type I natural killer T (NKT) cells are innate-like T lymphocytes that recognize glycolipid antigens presented by the MHC class I-like protein CD1d. Agonistic activation of NKT cells leads to rapid pro-inflammatory and immune modulatory cytokine and chemokine responses. This property of NKT cells, in conjunction with their interactions with antigen-presenting cells, controls downstream innate and adaptive immune responses against cancers and infectious diseases, as well as in several inflammatory disorders. NKT cell properties are acquired during development in the thymus and by interactions with the host microbial consortium in the gut, the nature of which can be influenced by NKT cells. This latter property, together with the role of the host microbiota in cancer therapy, necessitates a new perspective. Hence, this review provides an initial approach to understanding NKT cells from an ecological evolutionary developmental biology (eco-evo-devo) perspective.


Journal of Immunology | 2011

Proteasomes, TAP, and Endoplasmic Reticulum-Associated Aminopeptidase Associated with Antigen Processing Control CD4+ Th Cell Responses by Regulating Indirect Presentation of MHC Class II-Restricted Cytoplasmic Antigens

Srdjan Dragovic; Timothy Hill; Gregory J. Christianson; Sungjune Kim; Tim Elliott; Diane Scott; Derry C. Roopenian; Luc Van Kaer; Sebastian Joyce

Cytoplasmic Ags derived from viruses, cytosolic bacteria, tumors, and allografts are presented to T cells by MHC class I or class II molecules. In the case of class II-restricted Ags, professional APCs acquire them during uptake of dead class II-negative cells and present them via a process called indirect presentation. It is generally assumed that the cytosolic Ag-processing machinery, which supplies peptides for presentation by class I molecules, plays very little role in indirect presentation of class II-restricted cytoplasmic Ags. Remarkably, upon testing this assumption, we found that proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with Ag processing, but not tapasin, partially destroyed or removed cytoplasmic class II-restricted Ags, such that their inhibition or deficiency led to dramatically increased Th cell responses to allograft (HY) and microbial (Listeria monocytogenes) Ags, both of which are indirectly presented. This effect was neither due to enhanced endoplasmic reticulum-associated degradation nor competition for Ag between class I and class II molecules. From these findings, a novel model emerged in which the cytosolic Ag-processing machinery regulates the quantity of cytoplasmic peptides available for presentation by class II molecules and, hence, modulates Th cell responses.


Scientific Reports | 2017

NF-κB Protects NKT Cells from Tumor Necrosis Factor Receptor 1-induced Death.

A Kumar; Laura E. Gordy; Jelena S. Bezbradica; Aleksandar K. Stanic; Timothy Hill; Mark Boothby; L Van Kaer; Sebastian Joyce

Semi-invariant natural killer T (NKT) cells are innate-like lymphocytes with immunoregulatory properties. NKT cell survival during development requires signal processing by activated RelA/NF-κB. Nonetheless, the upstream signal(s) integrated by NF-κB in developing NKT cells remains incompletely defined. We show that the introgression of Bcl-xL-coding Bcl2l1 transgene into NF-κB signalling-deficient IκBΔN transgenic mouse rescues NKT cell development and differentiation in this mouse model. We reasoned that NF-κB activation was protecting developing NKT cells from death signals emanating either from high affinity agonist recognition by the T cell receptor (TCR) or from a death receptor, such as tumor necrosis factor receptor 1 (TNFR1) or Fas. Surprisingly, the single and combined deficiency in PKC-θ or CARMA-1—the two signal transducers at the NKT TCR proximal signalling node—only partially recapitulated the NKT cell deficiency observed in IκBΔNtg mouse. Accordingly, introgression of the Bcl2l1 transgene into PKC-θ null mouse failed to rescue NKT cell development. Instead, TNFR1-deficiency, but not the Fas-deficiency, rescued NKT cell development in IκBΔNtg mice. Consistent with this finding, treatment of thymocytes with an antagonist of the inhibitor of κB kinase —which blocks downstream NF-κB activation— sensitized NKT cells to TNF-α-induced cell death in vitro. Hence, we conclude that signal integration by NF-κB protects developing NKT cells from death signals emanating from TNFR1, but not from the NKT TCR or Fas.


Rheologica Acta | 2018

Evaluating rheological models for human blood using steady state, transient, and oscillatory shear predictions

Matthew J. Armstrong; Jeffrey S. Horner; Michael Clark; Michael Deegan; Timothy Hill; Charles Keith; Lynne Mooradian

The rheological characterization of human blood, through modeling and analysis of steady state, transient, and oscillatory shear flows, has made tremendous progress recently. Due to the aggregation of red blood cells at low shear rates, many recent models for blood rheology include a structural, thixotropic component with one of the most recent attempts unifying this approach with a viscoelastic formulation. We will show how these models, along with proposed modifications to another recent structural, kinetic thixotropy model, can improve modeling predictions. Results are compared to the Maxwell-like Bautista-Manero-Puig model, the Oldroyd-8 inspired viscoelastic Anand-Kwack-Masud model, a viscoelastic-thixotropic model from Blackwell and Ewoldt, and the Herschel-Bulkley model. We explore the weaknesses of the legacy blood models and then demonstrate the efficacy of the newly improved models for modeling human blood steady state and transient shear rheology to predict oscillatory shear flow.


Journal of Cell Biology | 2006

In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules

Jingbo Yan; Vrajesh V. Parekh; Yanice Mendez-Fernandez; Danyvid Olivares-Villagómez; Srdjan Dragovic; Timothy Hill; Derry C. Roopenian; Sebastian Joyce; Luc Van Kaer

Yan et al. 2006. J. Exp. Med. doi:10.1084/jem.20052271[OpenUrl][1][Abstract/FREE Full Text][2] [1]: {openurl}?query=rft.jtitle%253DJ.%2BExp.%2BMed.%26rft_id%253Dinfo%253Adoi%252F10.1084%252Fjem.20052271%26rft_id%253Dinfo%253Apmid%252F16505142%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%


Proceedings of the National Academy of Sciences of the United States of America | 2005

Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny.

Jelena S. Bezbradica; Timothy Hill; Aleksandar K. Stanic; L Van Kaer; Sebastian Joyce


Immunity | 2006

Granulocyte-Macrophage Colony-Stimulating Factor Regulates Effector Differentiation of Invariant Natural Killer T Cells during Thymic Ontogeny

Jelena S. Bezbradica; Laura E. Gordy; Aleksandar K. Stanic; Srdjan Dragovic; Timothy Hill; Jacek Hawiger; Derya Unutmaz; Luc Van Kaer; Sebastian Joyce

Collaboration


Dive into the Timothy Hill's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kelli L. Boyd

Vanderbilt University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge